Pharmacodynamic profiling of antimicrobials against Gram-negative respiratory isolates from Canadian hospitals

about

Pharmacodynamic profiling of antimicrobials against Gram-negative respiratory isolates from Canadian hospitals

Item

http://www.wikidata.org/entity/Q35569189

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Pharmacodynamic profiling of a ...... olates from Canadian hospitals

@ast

Pharmacodynamic profiling of a ...... olates from Canadian hospitals

@en

type

Item

label

Pharmacodynamic profiling of a ...... olates from Canadian hospitals

@ast

Pharmacodynamic profiling of a ...... olates from Canadian hospitals

@en

prefLabel

Pharmacodynamic profiling of a ...... olates from Canadian hospitals

@ast

Pharmacodynamic profiling of a ...... olates from Canadian hospitals

@en

P1476

Pharmacodynamic profiling of a ...... olates from Canadian hospitals

@en

P2093

David P Nicolau

http://www.w3.org/2001/XMLSchema#string

Rebecca A Keel

http://www.w3.org/2001/XMLSchema#string

Sheryl Zelenitsky

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa.

Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data.

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

Predicting efficacy of antiinfectives with pharmacodynamics and Monte Carlo simulation.

Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

P304

132-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/971701

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

George G Zhanel

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23205024

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

P932

3222759

http://www.w3.org/2001/XMLSchema#string